ArticleThe American journal of case reports2025
Allergic Bronchopulmonary Aspergillosis Presenting With Pulmonary Solid Lesions and Elevated Serum Carcinoembryonic Antigen Mimicking Lung Cancer.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder that occurs in patients allergic to Aspergillus species. It is typically characterized by reversible airway obstruction, transient pulmonary infiltrates, eosinophilia, and fever. Chest radiographs and high-resolution computed tomography (CT) are essential for diagnosis and differential diagnosis. Carcinoembryonic antigen (CEA), a tumor-specific marker, is often elevated in various malignant tumors but can also be increased in nonmalignant conditions. This overlap can result in misdiagnosis and unnecessary anxiety, leading to inappropriate clinical management. We report a case of ABPA presenting with pulmonary shadows that mimicked lung cancer, as well as elevated serum CEA levels. This report aims to enhance clinicians' understanding of ABPA, improve diagnostic accuracy, and reduce the likelihood of misdiagnosis or missed diagnosis. CASE REPORT A 39-year-old woman with a history of bronchial asthma presented with a productive cough. Chest CT revealed solid lesions in the left upper pulmonary lobe with mediastinal lymphadenopathy. Her serum CEA level was elevated, raising suspicion of malignancy. A positron emission tomography-CT scan demonstrated increased fluorodeoxyglucose uptake in the lungs. However, a CT-guided percutaneous lung biopsy, combined with other relevant diagnostic tests, confirmed ABPA according to the International Society for Human and Animal Mycology (ISHAM) criteria. After corticosteroid therapy, both the radiographic findings and serum CEA levels improved. CONCLUSIONS To avoid unnecessary invasive procedures and misdiagnosis of malignancy, ABPA should be considered in the differential diagnosis of patients with asthma who present with pulmonary solid lesions and elevated serum CEA levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.